Detection and Quantification of Polymorphic MICA and MICB Molecules in Immunoassays: Initial Insights
Authors:
- A. Yu. StolbovayaASA. Yu. Stolbovaya
- A. A. PinevichAPA. A. Pinevich
- I. V. GryazevaIGI. V. Gryazeva
- I. Yu. KrutetskayaIKI. Yu. Krutetskaya
- G. M. ZharinovGZG. M. Zharinov
- M. A. MorozovaMMM. A. Morozova
- A. Yu. KneevAKA. Yu. Kneev
- L. A. TerekhinaLTL. A. Terekhina
- O. A. ShashkovaOSO. A. Shashkova
- N. L. VartanianNVN. L. Vartanian
- M. P. SamoylovichMSM. P. Samoylovich
Abstract
The MICA and MICB molecules, expressed on the cell membrane in response to cellular stress or cancer transformation, pose significant challenges for immunoassays. They exhibit high sequence and structural similarity, alongside considerable allelic polymorphism, with 291 and 53 known protein sequences, respectively. Some researchers treat MICA and MICB as a unified target because of their structural and functional similarities, while others distinguish between them. However, which approach is superior and under what circumstances remains unknown. Moreover, information about assays' reactivity with MICA and MICB allelic variants is often missing. In this study, we developed 10 monoclonal antibodies (mAbs) and two sandwich ELISAs for the detection and quantification of these molecules. We assembled a panel of recombinant proteins representing the diversity of MICA and MICB in the European population and profiled the reactivities of the mAbs and ELISAs. The performance of these sandwich ELISAs was evaluated using samples from prostate cancer patients and pregnant women experiencing premature rupture of membranes. Our study assessed the impact of MICA and MICB polymorphism on their detection and quantification by immunological methods, providing evidence to support differential or non‐differential approaches for their detection.Keywords
Funding Information
- Russian Science Foundation (21‐15‐00021)
This publication has 67 references indexed in Scilit:
- NKG2D and MICA/B shedding: a ‘tag game’ between NK cells and malignant cellsClinical & Translational Immunology, 2020
- Soluble MICA is elevated in pancreatic cancer: Results from a population based case‐control studyMolecular Carcinogenesis, 2017
- The MICA-129Met/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICAImmunogenetics, 2015
- High diversity of MIC genes in non-human primatesImmunogenetics, 2014
- IMGT/DomainGapAlign: The IMGT® Tool for the Analysis of IG, TR, MH, IgSF, and MhSF Domain Amino Acid Polymorphism2012
- Transcriptional regulation of MICA and MICB: A novel polymorphism in MICB promoter alters transcriptional regulation by Sp1European Journal of Immunology, 2007
- Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing γδ T cell cytotoxicityInternational Journal of Cancer, 2006
- Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patientsInternational Journal of Cancer, 2005
- Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein familyImmunogenetics, 2001
- MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytesImmunogenetics, 1997